Showing results (261-270 of 299) with videos related to

Sort By:
Pageof 30
Experimental & Molecular Medicine|August 11, 2019
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancerDong Ha Kim, HyeongRyul Kim, Yun Jung Choi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Association Between Duration of Aminoglycoside Treatment and Outcome of Cavitary Mycobacterium avium Complex Lung DiseaseOck-Hwa Kim, Byoung Soo Kwon, Minkyu Han, et al.
Medicine|October 18, 2022
Lifestyle interventions after colorectal cancer surgery using a mobile digital device: A study protocol for a randomized controlled trialYoung Il Kim, In Ja Park, Chan Wook Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2011
Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergillomaSeong Yeon Park, Sang-Oh Lee, Sang-Ho Choi, et al.
Future Oncology (London, England)|March 6, 2023
TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumorsMisako Nagasaka, Yuichiro Ohe, Caicun Zhou, et al.
The European Respiratory Journal|January 9, 2025
Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisationDong Ha Kim, Kyungtaek Im, In-Jeoung Baek, et al.
The Clinical Respiratory Journal|January 5, 2025
Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR MutationChang Dong Yeo, Dong Won Park, Seong Hoon Yoon, et al.
Anticancer Research|February 27, 2022
First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South KoreaMi-Hyun Kim, Chang Min Choi, Sung Yong Lee, et al.
Journal of Thoracic Disease|November 4, 2020
Characteristics of female lung cancer in Korea: analysis of Korean National Lung Cancer RegistryJeong Uk Lim, Solji Han, Ho Cheol Kim, et al.
Cancer Medicine|July 14, 2021
Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South KoreaTaeyun Kim, Tae Won Jang, Chang Min Choi, et al.
Pageof 30